Eisai Co. Ltd is one of the known Japanese pharmaceutical companies which rank in the top 25 enterprises of the country. Eisai Co is traced to have its roots way back to 1936 when Toyoji Naito founded the limited partnership enterprise named as Sakuragaoka Research Laboratory. The present Eisai Co Ltd was however, established in the year 1941 with its headquarters based at Tokyo, Japan. The initial company was named as Nihon Eisai Co Ltd.

 

The company is amongst leading international pharmaceuticals companies employing nearly 9,000 people of which almost 1,500 are aggressively involved in the research and development sector. The major activities of the group involve producing and selling of pharmaceuticals products globally being operated through various divisions like: Pharmaceuticals and Other. Pharma division takes care of medical supplies for medical treatments, general medications and diagnostic supplies while other division caters the chemicals, food additives and machineries.

 

The foreign joint-venture subsidiaries of Eisai Group are in the different countries like: United States, Canada, France, Germany, Far East as well South-east Asian nations. The company today is amongst very few others that carry out extensive world-wide growth through significant network investments in the group’s foreign associates. Such associate members undertake research and development, production and sales as well as marketing of the products in places like United States, European Union and Asian nations.

 

Amongst many latest vital molecules developed by the company includes Donepezil used in formulating the renowned brand called Aricept and Rabeprazole used for preparing another flagship brand of the company known as Aciphex. Other most popular brands include: Cerebyx, Zonegran and Fragmin.